4 Peripheral T-Cell Lymphoma Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting Peripheral T-Cell Lymphoma Studies in New Haven

NCT05978141Recruiting

A Registry for People With T-cell Lymphoma

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more a...

New Haven, CT1,000 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06561048Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapse...

New Haven, CTPHASE3150 participantsCorvus Pharmaceuticals, Inc.

View Study Details

NCT04747236Recruiting

Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...

New Haven, CTPHASE250 participantsUniversity of Virginia

View Study Details

NCT05313243Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

This is a single arm, open label, multicenter study phase 2 study of pembrolizumab and brentuximab in subjects with relapsed/refractory CD30 positive T-cell lymphoma (including peripheral T-cell lymph...

New Haven, CTPHASE232 participantsYale University

View Study Details

About Peripheral T-Cell Lymphoma Clinical Trials in New Haven

Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.

There are currently 4 peripheral t-cell lymphoma clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 1,232 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Corvus Pharmaceuticals, Inc., University of Virginia and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral T-Cell Lymphoma Clinical Trials in New Haven — FAQ

Are there peripheral t-cell lymphoma clinical trials in New Haven?

Yes, there are 4 peripheral t-cell lymphoma clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What peripheral t-cell lymphoma treatments are being tested?

The 4 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov